Candesartan cilexetil
|
|
|
- CAS-Nr.
- 145040-37-5
- Englisch Name:
- Candesartan cilexetil
- Synonyma:
- Atacand;Blopress;Candesartan cilexeti;Candesartan cilexetil for peak identification;tcv116;exetiL;TCY 116;Candestartan;Candesartan CiL;Cadesartan cilexetil
- CBNumber:
- CB3209325
- Summenformel:
- C33H34N6O6
- Molgewicht:
- 610.66
- MOL-Datei:
- 145040-37-5.mol
|
Candesartan cilexetil Eigenschaften
- Schmelzpunkt:
- 168-170?C
- Siedepunkt:
- 843.3±75.0 °C(Predicted)
- Dichte
- 1.37±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: ≥15mg/mL
- pka
- pKa 3.55 (H2O t=25.0 I=0.025) (Uncertain);5.91(H2O t=25.0 I=0.025) (Uncertain)
- Aggregatzustand
- powder
- Farbe
- white to beige
- maximale Wellenl?nge (λmax)
- 304nm(EtOH)(lit.)
- Merck
- 14,1739
- BCS Class
- 2
- InChIKey
- GHOSNRCGJFBJIB-UHFFFAOYSA-N
- SMILES
- C1(OCC)N(CC2=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C2)C2=C(C(OC(OC(OC3CCCCC3)=O)C)=O)C=CC=C2N=1
- CAS Datenbank
- 145040-37-5(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher |
Xn,N,T |
|
|
| R-S?tze: |
20/21/22-36/37/38-50-48/20-61 |
|
|
| S-S?tze: |
26-36-61-45-53 |
|
|
| WGK Germany |
3 |
|
|
| RTECS-Nr. |
DD6672500 |
|
|
| HS Code |
29339953 |
|
|
| Toxizit?t |
dog,LD50,oral,> 2gm/kg (2000mg/kg),Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 406, 2000. |
|
|
| Bildanzeige (GHS) |
 
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H361 |
Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Reproduktionstoxizit?t |
Kategorie 2 |
Warnung |
|
P201, P202, P281, P308+P313, P405,P501 |
| H400 |
Sehr giftig für Wasserorganismen. |
Kurzfristig (akut) gew?ssergef?hrdend |
Kategorie 1 |
Warnung |
![GHS hazard pictograms]() src="/GHS09.jpg" width="20" height="20" /> |
P273, P391, P501 |
|
| Sicherheit |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
|
Candesartan cilexetil Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R20/21/22:Gesundheitssch?dlich beim Einatmen,Verschlucken und Berührung mit der Haut.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Chemische Eigenschaften
It appears as a white or off-white powder.It is soluble in methanol but insoluble in water.
Allgemeine Beschreibung
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Candesartan cilexetil Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Candesartan cilexetil Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 695)Lieferanten
145040-37-5()Verwandte Suche:
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
- Candesantan Cilexetil
- 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2
- 1-(Cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-b
- 1-(((cyclohexyloxy)carbonyl)oxy)ethylester,(+-)-henyl)-4-yl)methyl)
- 1h-benzimidazole-7-carboxylicacid,2-ethoxy-1-((2’-(1h-tetrazol-5-yl)(1,1’-bip
- tcv116
- CANDESARTAN CILEXITIL
- CANDESARTAN CILEXETIL
- 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate
- Candesartan Celexetil Ester
- Candesartan Cilexetil (100 mg)
- Candestartan
- 2-ETHOXY-3-[2''-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID 1-CYCLOHEXYLOXYCARBONYLOXY-ETHYL ESTER
- Cadesartan cilexetil
- 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-
- (+-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, (+-)-
- TCY 116
- Candesartan Cilexetil API
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-et
- 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
- Candesartan cilexetil for system suitability
- CandesartanCilexetil99.0%Min
- Calldesartan Cilexetil
- Candesartanciletexil
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- 2-ethoxy-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]benzimidazole-4-carboxylic acid 1-(cyclohexoxycarbonyloxy)ethyl ester
- 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl ester
- 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
- High purity Antihypertensive Powder Candesartan cilexetil CAS 145040-37-5 CAS NO.145040-37-5
- Candesartan cilexetil, 98%, an ATR antagonist
- Candesartan Cilexetil (C11)
- Candesartan cilexetil CRS
- Candesartan cilexetil for system suitability CRS
- Candesartan Cilexetil >
- Candesartan cilexetil for peak identification CRS
- Candesartan CiL
- exetiL
- Candesartan cilexetil USP/EP/BP
- 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
- Candesartan Cilexetil (CV 11974)
- candesartan cilexetil impurity1363
- Candesartan Cilexetil (Y0001388)Q: What is
Candesartan Cilexetil (Y0001388) Q: What is the CAS Number of
Candesartan Cilexetil (Y0001388)
- Candesartan cilexetil for peak identification (Y0001387)
- Candesartan cilexetil for system suitability (Y0001389)Q: What is
Candesartan cilexetil for system suitability (Y0001389) Q: What is the CAS Number of
Candesartan cilexetil for system suitability (Y0001389)
- Candesartan cilexetilQ: What is
Candesartan cilexetil Q: What is the CAS Number of
Candesartan cilexetil Q: What is the storage condition of
Candesartan cilexetil Q: What are the applications of
Candesartan cilexetil
- Candesartan Cilexetil (1087803)
- Candesartan cilexeti
- Atacand
- Candesartan cilexetil for peak identification
- Blopress
- {[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-
1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-
1H-benzimidazole-7-carboxylate
- Candesartan Cilexetil
1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-
carboxylate
